Skip to main content
Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0370
0.00 (0.00%)
Apr 28, 2025, 4:00 PM EDT

PLSH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-7.67-8.02-9.14-4.78-5.23-2.81
Depreciation & Amortization
1.671.711.731.741.690.79
Other Amortization
-0.041.070.12--
Loss (Gain) From Sale of Assets
---0.30.140.49
Loss (Gain) From Sale of Investments
0.921.092.64-1.17-1.43-0.13
Other Operating Activities
0.610.61-0.25-0.76--0.23
Change in Accounts Receivable
0.490.430.04-0.10.15-0.15
Change in Inventory
-0.110.3-0.18-0.55-5.05-2.92
Change in Accounts Payable
2.141.991.081.070.650.81
Change in Other Net Operating Assets
0.380.320.620.211.420.25
Operating Cash Flow
-1.57-1.52-2.4-3.92-7.65-3.89
Capital Expenditures
-0.06-0.07-0.24-0.16-3.2-6.98
Sale of Property, Plant & Equipment
---0.450.12-
Cash Acquisitions
---0.01--
Investment in Securities
--0.050.23--
Investing Cash Flow
-0.06-0.07-0.20.52-3.08-6.98
Short-Term Debt Issued
-0.290.253.556.2615.73
Long-Term Debt Issued
-1.84.09---
Total Debt Issued
1.942.094.343.556.2615.73
Short-Term Debt Repaid
------2.58
Long-Term Debt Repaid
--0.41-1.76-0.21-3.96-
Total Debt Repaid
-0.29-0.41-1.76-0.21-3.96-2.58
Net Debt Issued (Repaid)
1.661.682.583.332.313.16
Issuance of Common Stock
-----0.37
Financing Cash Flow
1.661.682.583.332.318.52
Miscellaneous Cash Flow Adjustments
----0--
Net Cash Flow
0.030.09-0.01-0.06-8.437.65
Free Cash Flow
-1.62-1.59-2.64-4.09-10.85-10.87
Free Cash Flow Margin
-58.71%-66.66%-162.47%-198.34%-120.28%-494.42%
Free Cash Flow Per Share
-0.10-0.10-0.18-0.23-0.64-0.61
Cash Interest Paid
----0.58-
Levered Free Cash Flow
-0.17-0.06-1.260.51-9.02-
Unlevered Free Cash Flow
0.830.87-1.051.08-8.07-
Change in Net Working Capital
-2.53-2.69-1-3.223.28-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.